Home > Name List By a > acetic acid China

CAS No 129580-63-8 , acetic acid Search by region : China

  • Name: acetic acid
  • Synonyms: YHI-601; AKOS015914237;azane; BMS-182751; FT-0601550; Satraplatin (USAN/INN);acetic acid; JM-216;dichloroplatinum; D05807; BMY-45594;cyclohexanamine;129580-63-8;
  • CAS Registry Number:
  • Flash Point: 32.2 ºC
  • Boiling Point: 134.5 ºCat 760 mmHg
  • Density: g/cm3
  • Flash Point: 32.2 ºC
  • Molecular Weight: 502.29856
  • InchiKey: TWEQNPPRXJRHHM-UHFFFAOYSA-L
  • InChI: InChI=1S/C6H13N.2C2H4O2.2ClH.H3N.Pt/c7-6-4-2-1-3-5-6;2*1-2(3)4;;;;/h6H,
    1-5,7H2;2*1H3,(H,3,4);2*1H;1H3;/q;;;;;;+2/p-2
  • Molecular Formula: C10H24Cl2N2O4Pt
  • Molecular Structure:CAS No:129580-63-8 acetic acid

Select to

129580-63-8 Satraplatin

Contact Supplier

129580-63-8 Satraplatin

  • China shanghai sphchem co.,ltd [Manufacturers]
  • Tel: +86-21-56491756 13512199871
  • Fax: 0
  • Address: NO.133, Wuye, Yangxin Road ,Shanghai China shanghai,shanghai ChinaChina
Contact Supplier

129580-63-8 Satraplatin

  • China Maple Chemical Co.,ltd. [Manufacturer]
  • Tel: 86-574- 87512300
  • Fax: 86-574-82095182
  • Address: No.347,Sanbei Road,Sanbei Town,Cixi ,Zhejiang,China Ningbo,ZhejiangChina
Contact Supplier

129580-63-8 Satraplatin

  • China Bo Jia Science and Technology (Wuhan) Co., Ltd. [Manufacturers]
  • Tel: 02787526690-8155
  • Fax: 86-027-87526527
  • Address: Wuhan City, Hubei Province Luo Yu Road, Hongshan No. 424 Technology Innovation Center, 14 Floor, Block A wuhan,hubeiChina
Contact Supplier

129580-63-8 Satraplatin

Contact Supplier

Select to

References of acetic acid
Title: Satraplatin
CAS Registry Number: 129580-63-8
CAS Name: (OC-6-43)-Bis(acetato-kO)amminedichloro(cyclohexanamine)-platinum
Synonyms: bis-acetato-ammine-dichloro-cyclohexylamine-platinum(IV)
Manufacturers' Codes: BMS-182751; BMY-45594; JM-216
Molecular Formula: C10H22Cl2N2O4Pt
Molecular Weight: 500.28
Percent Composition: C 24.01%, H 4.43%, Cl 14.17%, N 5.60%, O 12.79%, Pt 38.99%
Literature References: Orally active analog of cisplatin, q.v. Prepn: M. J. Abrams et al., EP 328274; eidem, US 5072011 (1989, 1991 both to Johnson Matthey). Clinical pharmacokinetics: S. Vouillamoz-Lorenz et al., Anticancer Res. 23, 2757 (2003). Clinical evaluation in small-cell lung cancer: E. Fokkema et al., J. Clin. Oncol. 17, 3822 (1999); in hormone-refractory prostate cancer: C. N. Sternberg et al., Oncology 68, 2 (2005). Review of clinical development: L. R. Kelland, Expert Opin. Invest. Drugs 9, 1373-1382 (2000).
Properties: Soly (mg/ml): water ~0.3; saline 0.4; 1-octanol 0.7. Partition coefficient (octanol/water): 0.1. LD50 in mice (mg/kg): 30 i.p.; 330 orally (Kelland).
Log P: Partition coefficient (octanol/water): 0.1
Toxicity data: LD50 in mice (mg/kg): 30 i.p.; 330 orally (Kelland)
Therap-Cat: Antineoplastic.
Keywords: Antineoplastic; Platinum Complexes.